Cargando…

Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity

BACKGROUND: Mixed (composite) exocrine-neuroendocrine cell carcinomas are defined as an intimate admixture of neoplastic glandular exocrine and neuroendocrine cell types. Although gastric adenocarcinoma containing a small number of neuroendocrine cells is a relatively frequent occurrence, gastric ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Nugent, Summer L, Cunningham, Steven C, Alexiev, Borislav A, Bellavance, Emily, Papadimitriou, John C, Hanna, Nader
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174438/
https://www.ncbi.nlm.nih.gov/pubmed/17988399
http://dx.doi.org/10.1186/1746-1596-2-43
_version_ 1782145339347697664
author Nugent, Summer L
Cunningham, Steven C
Alexiev, Borislav A
Bellavance, Emily
Papadimitriou, John C
Hanna, Nader
author_facet Nugent, Summer L
Cunningham, Steven C
Alexiev, Borislav A
Bellavance, Emily
Papadimitriou, John C
Hanna, Nader
author_sort Nugent, Summer L
collection PubMed
description BACKGROUND: Mixed (composite) exocrine-neuroendocrine cell carcinomas are defined as an intimate admixture of neoplastic glandular exocrine and neuroendocrine cell types. Although gastric adenocarcinoma containing a small number of neuroendocrine cells is a relatively frequent occurrence, gastric neoplasms containing equal proportions of both cell types are rare. CASE PRESENTATION: We present a case of composite exocrine (signet-ring cell)-neuroendocrine cell carcinoma, in which the neoplastic signet-ring cell exocrine and neuroendocrine constituents occurred in fairly equivalent amounts, whereas only the neuroendocrine carcinoma portion of the tumor represented the metastatic component. Light microscopy, immunohistochemical and electron microscopic findings are described, and the literature is reviewed. CONCLUSION: This study confirms the ability of pluripotent precursor cells to differentiate into either adenocarcinoma or neuroendocrine tumor and, justifying the designation of composite exocrine-neuroendocrine cell carcinoma as the appropriate classification for this tumor. The protracted clinical course further supports the notion that composite signet-ring cell/neuroendocrine carcinoma tumors behave relatively less aggressively than the pure forms of the former cell type.
format Text
id pubmed-2174438
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21744382008-01-04 Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity Nugent, Summer L Cunningham, Steven C Alexiev, Borislav A Bellavance, Emily Papadimitriou, John C Hanna, Nader Diagn Pathol Case Report BACKGROUND: Mixed (composite) exocrine-neuroendocrine cell carcinomas are defined as an intimate admixture of neoplastic glandular exocrine and neuroendocrine cell types. Although gastric adenocarcinoma containing a small number of neuroendocrine cells is a relatively frequent occurrence, gastric neoplasms containing equal proportions of both cell types are rare. CASE PRESENTATION: We present a case of composite exocrine (signet-ring cell)-neuroendocrine cell carcinoma, in which the neoplastic signet-ring cell exocrine and neuroendocrine constituents occurred in fairly equivalent amounts, whereas only the neuroendocrine carcinoma portion of the tumor represented the metastatic component. Light microscopy, immunohistochemical and electron microscopic findings are described, and the literature is reviewed. CONCLUSION: This study confirms the ability of pluripotent precursor cells to differentiate into either adenocarcinoma or neuroendocrine tumor and, justifying the designation of composite exocrine-neuroendocrine cell carcinoma as the appropriate classification for this tumor. The protracted clinical course further supports the notion that composite signet-ring cell/neuroendocrine carcinoma tumors behave relatively less aggressively than the pure forms of the former cell type. BioMed Central 2007-11-07 /pmc/articles/PMC2174438/ /pubmed/17988399 http://dx.doi.org/10.1186/1746-1596-2-43 Text en Copyright © 2007 Nugent et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Nugent, Summer L
Cunningham, Steven C
Alexiev, Borislav A
Bellavance, Emily
Papadimitriou, John C
Hanna, Nader
Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
title Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
title_full Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
title_fullStr Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
title_full_unstemmed Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
title_short Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
title_sort composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174438/
https://www.ncbi.nlm.nih.gov/pubmed/17988399
http://dx.doi.org/10.1186/1746-1596-2-43
work_keys_str_mv AT nugentsummerl compositesignetringcellneuroendocrinecarcinomaofthestomachwithametastaticneuroendocrinecarcinomacomponentabetterprognosisentity
AT cunninghamstevenc compositesignetringcellneuroendocrinecarcinomaofthestomachwithametastaticneuroendocrinecarcinomacomponentabetterprognosisentity
AT alexievborislava compositesignetringcellneuroendocrinecarcinomaofthestomachwithametastaticneuroendocrinecarcinomacomponentabetterprognosisentity
AT bellavanceemily compositesignetringcellneuroendocrinecarcinomaofthestomachwithametastaticneuroendocrinecarcinomacomponentabetterprognosisentity
AT papadimitrioujohnc compositesignetringcellneuroendocrinecarcinomaofthestomachwithametastaticneuroendocrinecarcinomacomponentabetterprognosisentity
AT hannanader compositesignetringcellneuroendocrinecarcinomaofthestomachwithametastaticneuroendocrinecarcinomacomponentabetterprognosisentity